| Abbreviation | Definition |
| ACE | Angiotensin-Converting Enzyme |
| AF | Atrial Fibrillation |
| ANOVA | Analysis of Variance |
| ARB | Angiotensin Receptor Blocker |
| CBC | Complete Blood Count |
| CI | Confidence Interval |
| CKD | Chronic Kidney Disease |
| ECG | Electrocardiography |
| ESC | European Society of Cardiology |
| FDA | U.S. Food and Drug Administration |
| HF | Heart Failure |
| HFrEF | Heart Failure with Reduced Ejection Fraction |
| HFmrEF | Heart Failure with Mid-Range Ejection Fraction |
| HFpEF | Heart Failure with Preserved Ejection Fraction |
| HR | Hazard Ratio |
| ICD | Implantable Cardioverter-Defibrillator |
| IV | Intravenous |
| LVEF | Left Ventricular Ejection Fraction |
| NYHA | New York Heart Association |
| NT-proBNP | N-terminal pro–B-type Natriuretic Peptide |
| OR | Odds Ratio |
| RAAS | Renin–Angiotensin–Aldosterone System |
| RCT | Randomized Controlled Trial |
| SD | Standard Deviation |
| SGLT2 | Sodium–Glucose Cotransporter 2 |
| WHO | World Health Organization |